Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma

Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma

Researchers Discover New Drugs That Inhibit a “Master Switch” in a Deadly Non-Hodgkin’s Lymphoma

New CAR T approach minimizes resistance, helps avoid relapse in non-Hodgkin's B-cell lymphoma